Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 15 points (0.1%) at 16,035 as of Monday, Dec. 9, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,480 issues advancing vs. 1,397 declining with 175 unchanged. The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Given Imaging ( GIVN), up 25.8%, DaVita HealthCare Partners ( DVA), up 4.3%, Parexel International Corporation ( PRXL), up 4.2%, Grifols ( GRFS), up 0.9% and Humana ( HUM), up 0.7%. A company within the industry that fell today was Centene Corporation ( CNC), up 2.7%. TheStreet would like to highlight 5 stocks pushing the industry higher today: 5. Cigna ( CI) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cigna is up $1.00 (1.2%) to $87.50 on average volume. Thus far, 671,369 shares of Cigna exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $87.21-$87.93 after having opened the day at $87.51 as compared to the previous trading day's close of $86.50. Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $23.3 billion and is part of the health care sector. The company has a P/E ratio of 12.8, below the S&P 500 P/E ratio of 17.7. Shares are up 57.7% year to date as of the close of trading on Friday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold. TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cigna Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.